Nektar Therapeutics NKTR
NASDAQ NKTR
$37.22 -1.43 (-3.70%)
At close: Oct 23, 2026 · 4:00 PM EDT

Nektar Therapeutics (NKTR) Sale and Maturity of Investments (2010 - 2026)

Updated

Analysis

Nektar Therapeutics (NKTR) Sale and Maturity of Investments (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Nektar Therapeutics 1.23 Bn -538.60 Mn - 136.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 136.44 Mn
Mar 31, 2026 101.48 Mn
Dec 31, 2025 91.99 Mn
Sep 30, 2025 54.80 Mn
Jun 30, 2025 68.57 Mn
Mar 31, 2025 69.32 Mn
Dec 31, 2024 65.11 Mn
Sep 30, 2024 65.16 Mn
Jun 30, 2024 85.61 Mn
Mar 31, 2024 124.47 Mn
Dec 31, 2023 156.50 Mn
Sep 30, 2023 178.30 Mn
Jun 30, 2023 168.05 Mn
Mar 31, 2023 148.04 Mn
Dec 31, 2022 199.81 Mn
Sep 30, 2022 160.00 Mn
Jun 30, 2022 238.45 Mn
Mar 31, 2022 227.97 Mn
Dec 31, 2021 270.73 Mn
Sep 30, 2021 290.27 Mn
API Access

Nektar Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=NKTR&period=max&api_key=YOUR_API_KEY